FDA Panel Flags Insufficient Data for Chronic Cough Drug : v

Advisers to the FDA said that data on Merck's chronic cough drug do not provide sufficient evidence to prove its clinical benefit for patients.

Related Keywords

Bengaluru , Karnataka , India , Khushi Mandowara , Emma Dagostino , Christy Santhosh , Shounak Dasgupta , Reuters , Cystic Fibrosis Foundation , Drug Administration , Emmad Agostino , Patient Safety , Otolaryngology , Nt Specialty , Ead And Neck Surgery Ent Speciality , Chronic Cough , Drug Development , Drug Discovery , Drug Pipeline , Drug Development Pipeline , Experimental Drug , Cough , Russis , Adverse Effects , Side Effects , Cystic Fibrosis , Us Food And Drug Administration , Nited States Food And Drug Administration , Fda , Refractory ,